Riize
Riize is a US-based DTC telemedicine platform selling prescription and OTC health products — primarily men's ED, women's sexual wellness, hair loss, and weight management — through proprietary oral dissolving thin-film strip technology and online physician consultations with discreet home delivery.
- Company typePrivate
- Founded2023
- HeadquartersMiami, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Riize does
Riize LLC is a US-based direct-to-consumer telemedicine platform that sells prescription and over-the-counter health products through an integrated online consultation, prescribing, and home-delivery model. Founded in 2023 and headquartered in Miami (with a Houston mailing address), the company operates as a wholly-owned subsidiary of iMD Companies, Inc. (OTC: ICBU) following an August 2024 acquisition. Its primary customers are individual adults seeking treatment for sensitive health conditions, with the strongest focus on men's erectile dysfunction, women's sexual wellness, hair loss, and weight management; the company also sells general wellness OTC strips (energy, sleep, digestion, hangover, motion sickness). All transactions occur online: consumers complete a health questionnaire, consult with US board-certified physicians via the Riize telemedicine platform, and receive discreet home delivery.
The company's core technical differentiator is its proprietary Rapid Enhanced Dissolving Strips (REDS) oral thin-film delivery system, which it manufactures domestically and claims delivers active ingredients with up to 90% bioavailability and 3-6x faster onset than traditional oral medications by using buccal/sublingual absorption. Notable compounded formulations include Riize Max Strips (sildenafil + tadalafil + oxytocin for ED), Riize Pinks (PT-141 peptide for women's libido), Riize Hair (minoxidil + finasteride + biotin), and an oral semaglutide weight-maintenance strip, alongside a portfolio of OTC supplement strips. Pricing is not publicly disclosed, but prescription products are positioned as subscription-recurring while OTC supplements are sold on a one-time basis, with a promotional 50% first-order discount code in market.
Revenue mechanics combine DTC subscription prescription revenue, one-time OTC supplement sales, and — launched in late 2024 — a white-label and technology licensing program that monetizes the REDS platform to external brand partners. The company reports a 6x increase in sales order volume and 3x increase in online subscriber base between September 2023 and March 2024, and has executed multiple adjacent moves in 2024 including product line extensions, entry into Canada, and the white-label vertical. No external venture funding rounds are disclosed; pre-acquisition growth appears to have been self-funded through operations, and the parent company iMD provides public-market capital access.
Riize firmographics
Firmographics- Name
- Riize
- Legal name
- Riize LLC
- Website
- https://riizehealth.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Riize is a US-based DTC telemedicine platform selling prescription and OTC health products — primarily men's ED, women's sexual wellness, hair loss, and weight management — through proprietary oral dissolving thin-film strip technology and online physician consultations with discreet home delivery.
- Ownership category
- akta.pro rank
Riize industry classification
Industry- Product category
- Telemedicine Health Services
- NAICS
- Soap and Cleaning Compound Manufacturing (32561), Other Personal Care Services (812199)
- SIC
- Services-Health Services (8000), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Men’s Health (OTC Urologic & Sexual Health) (HLAIADAK)
- akta.pro secondary industries
- Women’s Health (OTC Gynecologic) (HLAIADAJ), Sleep, Stress & Mood Support (HLAIADAG), Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief) (CRADAMAJ)
Keywords
Where Riize is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Riize business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel, Infrastructure
Revenue model
- Prescription Sexual Health Products: Prescription ED medications (Riize Max strips combining sildenafil and tadalafil) and women's sexual health products (Riize Pinks with PT-141) prescribed through licensed telemedicine providers and shipped directly to consumers.
- OTC Supplement Products: Non-prescription oral strip supplements including Energy, Extra, Digestive, Hangover, Motion, and Sleep products sold directly to consumers online.
- Hair Growth Products: Hair loss treatment products (Riize Hair) combining minoxidil, finasteride, and biotin available in topical drops or oral dissolving strips.
- Weight Management Products: Semaglutide-based weight loss strips for maintaining weight loss achieved through injectable forms.
- White Label and Licensing: White label program and technology licensing allowing other companies to use Riize's oral dissolving strip technology and branding.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Riize product offering
Product offeringCore offering
Riize Health is a direct-to-consumer telemedicine platform that connects individual patients with US board-certified physicians for online consultations and prescriptions, then dispatches branded prescription and OTC products delivered via its proprietary Rapid Enhanced Dissolving Strip (REDS) oral thin-film technology. The company primarily serves men and women with sexual wellness needs (ED, women's libido), weight management (oral semaglutide strips), hair growth (minoxidil/finasteride/biotin), and a line of general wellness OTC strips.
Product overview
Riize is a telemedicine platform offering a portfolio of prescription and non-prescription health products primarily delivered via proprietary oral dissolving thin film strip technology. The core prescription products include Riize Max Strips (men's ED treatment combining sildenafil, tadalafil, and oxytocin), Riize Pinks Strips (women's sexual health with PT-141 peptide), Riize Hair (hair loss treatment with minoxidil/finasteride), and Riize Weight Maintenance (semaglutide oral strip). The non-prescription supplement line includes Riize Energy, Riize Extra, Riize Digestive, Riize Hangover, Riize Motion, and Riize Sleep—all utilizing the same rapid-absorption oral strip delivery system. The company operates a telemedicine platform connecting patients with US board-certified physicians for consultations and prescriptions, with 100% online, discreet delivery.
Differentiator
Problem solved
Functional benefit
Brands
- Riize Max: Prescription ED strips with proprietary compound formula combining sildenafil, tadalafil, and oxytocin for erectile dysfunction treatment.
- Riize Pinks
- Riize Hair
- Riize Weight Maintenance
- Riize Extra
- Riize Digestive
- Riize Hangover
- Riize Motion
- Riize Sleep
- Riize Energy
Products and services
- Riize Max Strips Prescription erectile dysfunction oral dissolving strips combining sildenafil (Viagra), tadalafil (Cialis), and oxytocin on a proprietary rapidly dissolving oral film. Works 3x to 6x faster than other similar products with up to 90% bioavailability. Prescribed through licensed telemedicine providers and shipped directly to consumers.
- Riize Pinks Strips Women's sexual health oral dissolving strips using proprietary peptide PT-141 compound to increase feelings of intimacy, closeness and confidence. Fast-acting sublingual delivery via the REDS thin film platform; prescribed through the Riize telemedicine platform.
- Riize Hair Prescription male hair loss solution combining FDA-approved minoxidil, finasteride and biotin. Available in both topical drops and oral dissolving strips in three monthly package configurations.
- Riize Weight Maintenance Oral dissolving semaglutide strip providing micro-dosing level of semaglutide to support weight loss already achieved. Designed for patients with aversion to injectable GLP-1 forms.
- Riize Energy Energy boosting supplement oral strip containing caffeine, L-theanine, vitamin B12 and electrolytes for enhanced energy levels and mental clarity.
- Riize Extra Non-prescription sexual health supplement strip supporting libido and vitality containing testofen, chromium, selenium and ashwagandha.
- Riize Digestive Digestive health strip dissolving in seconds providing relief for upset stomach, gas, and bloating. Contains Emblica Officinalis, Foeniculum Vulgare, Carum Carvi, and Coleus Ambonicus Lour.
- Riize Hangover Hangover relief supplement strip containing glutathione, dihydromyricetin (DHM), N-acetylcysteine (NAC) and mannitol to help recovery after alcohol consumption.
- Riize Motion Motion sickness relief strip combining ginseng extract, magnesium, vitamin B6 and electrolytes in a non-drowsy formula.
- Riize Sleep Sleep aid strip with valerian root extract, melatonin, L-theanine and vitamin B6 for restful, rejuvenating sleep.
- Riize Telemedicine Platform Secure online healthcare platform connecting patients with US board-certified healthcare providers via video or phone consultations for personalized treatment plans. Enables remote diagnosis, prescriptions, and discreet home delivery of medications. HIPAA-compliant.
- White Label and Licensing Program White label and technology licensing program that allows other companies to use Riize's proprietary oral dissolving strip technology and branding for their own product lines.
Quantifiable outcome
- Delivers up to 90% of active ingredients directly to system
- +2 more outcomes
Companies that use Riize
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles4 records
Riize technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Riize partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- iMD Companies, Inc.coreiMD Companies, Inc. (OTC: ICBU) completed acquisition of Riize, LLC in August 2024. Riize operates as a wholly-owned subsidiary, bringing its telemedicine platform and oral dissolving strip technology under the parent company's portfolio. The acquisition was announced via letter of intent in August 2024 and completed by August 29, 2024.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Riize competitors and assessment
Company assessmentDirect peers
- Keeps: DTC telehealth platform focused exclusively on men's hair loss treatment (finasteride and minoxidil) — directly competing with Riize Hair. Same telemedicine consultation model, same target demographic, and same subscription recurring revenue structure.
- LifeMD: Publicly-traded DTC telehealth company offering virtual care, prescription medications, and over-the-counter products across weight management, men's and women's health, and primary care — overlapping with Riize's sexual health, weight, and hair offerings through a similar telemedicine + home delivery model.
- Lemonaid Health: Telehealth platform offering online consultations and prescriptions across multiple conditions including sexual health, hair loss, and mental health — a multi-category competitor structurally similar to Riize's portfolio approach, though with a less proprietary delivery format.
- BlueChew: Pure-play DTC telehealth subscription service for erectile dysfunction, offering chewable sildenafil and tadalafil formulations. Most direct head-to-head competitor to Riize Max, with overlapping patient demographics, telemedicine prescribing model, and discreet home delivery.
- Hims & Hers Health: The largest publicly-traded DTC telehealth platform in the US, offering prescription and OTC products for men's sexual health (ED), women's sexual health, hair loss, weight loss, and mental health — directly overlapping with every primary product line at Riize. Same direct-to-consumer telemedicine + home delivery model, same regulatory structure, and same target customer segments.
- Ro: Leading DTC men's health and telehealth platform operating brands including Roman (ED), Rory (women's health), and Ro Pharmacy — overlapping with Riize's sexual health, hair, and weight categories under an integrated telemedicine + fulfillment model. Direct competitor in men's sexual health with substantially larger marketing scale.
Emerging players
- Nutrafol: DTC hair wellness supplement brand offering clinically-backed nutraceuticals for hair growth — overlapping with Riize Hair from a clinically-positioned, subscription-based consumer brand angle, though without the prescription pharmaceutical component. Useful comparison for brand-building in hair wellness.
- Henry Meds: DTC telehealth platform offering prescription medications for weight management (including compounded semaglutide and tirzepatide), men's health, and women's health — directly comparable to Riize Weight Maintenance and broader portfolio approach, with a focus on compounded prescription offerings.
Broad incumbents
- GoodRx: Large publicly-traded healthcare platform combining prescription drug price transparency, telehealth consultations, and home delivery across thousands of medications. While not a sexual-health-focused brand, GoodRx's telehealth + pharmacy fulfillment capability puts it in overlapping categories (including ED, hair, and weight management) at significantly larger scale.
- Teladoc Health: Largest publicly-traded virtual care company in the US, providing general telemedicine services across many conditions including men's and women's health. A broad incumbent that demonstrates the structural viability of telemedicine-led prescription models but operates at a much larger, enterprise-focused scale than Riize's DTC approach.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Riize social profiles
Digital presenceRiize compliance and trust
Trust signalCompliance1 record
Riize financial estimates
Financial estimateRevenue estimate
Valuation estimate
Riize leadership team
Management profileNumber of profiles
Profiles2 records
Riize funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Riize M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Riize
What does Riize do?
Riize Health is a direct-to-consumer telemedicine platform that connects individual patients with US board-certified physicians for online consultations and prescriptions, then dispatches branded prescription and OTC products delivered via its proprietary Rapid Enhanced Dissolving Strip (REDS) oral thin-film technology. The company primarily serves men and women with sexual wellness needs (ED, women's libido), weight management (oral semaglutide strips), hair growth (minoxidil/finasteride/biotin), and a line of general wellness OTC strips.
Is Riize a public or private company?
Riize is a private company. It is classified as corporate owned and is currently operating.
When was Riize founded?
Riize was founded in 2023. It employs 11 to 50 people.
Where is Riize based?
Riize is headquartered in Miami, United States, in the North America region.
How does Riize make money?
Five revenue lines are on record. Prescription Sexual Health Products are the primary driver. The others are OTC Supplement Products, hair Growth Products, weight Management Products and white Label and Licensing.
Who are Riize's main competitors?
Direct peers on record are Keeps, LifeMD, Lemonaid Health, BlueChew, Hims & Hers Health and Ro. Emerging players are Nutrafol and Henry Meds. Broad incumbents are GoodRx and Teladoc Health.
Does Riize have an API?
No public API is recorded for Riize.
What industry is Riize in?
Riize's product category is Telemedicine Health Services. Its primary akta.pro industry code is HLAIADAK, Men’s Health (OTC Urologic & Sexual Health), with a secondary code of HLAIADAJ, Women’s Health (OTC Gynecologic). Its NAICS code is 32561 and its SIC code is 8000.